ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
11.15
-0.07 (-0.62%)
At close: Nov 5, 2025
ChemPartner PharmaTech Market Cap
ChemPartner PharmaTech has a market cap or net worth of 5.55 billion as of November 5, 2025. Its market cap has increased by 79.26% in one year.
Market Cap
5.55B
Enterprise Value
5.64B
Revenue
1.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
11.15
Market Cap Chart
Since December 22, 2010, ChemPartner PharmaTech's market cap has increased from 2.12B to 5.55B, an increase of 161.84%. That is a compound annual growth rate of 6.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 5.59B | 75.40% |
| Dec 31, 2024 | 3.19B | -16.38% |
| Dec 29, 2023 | 3.81B | -26.51% |
| Dec 30, 2022 | 5.18B | -24.67% |
| Dec 31, 2021 | 6.88B | -6.52% |
| Dec 31, 2020 | 7.36B | 11.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 411.60B |
| WuXi AppTec | 277.05B |
| Shenzhen Mindray Bio-Medical Electronics | 249.46B |
| Sichuan Biokin Pharmaceutical | 150.79B |
| Shanghai United Imaging Healthcare | 113.97B |
| Aier Eye Hospital Group | 111.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 105.91B |
| Yunnan Baiyao Group Co.,Ltd | 99.69B |